Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Business Insights
Cue Health receives FDA emergency use authorization for molecular mpox test
The test demonstrated high accuracy in clinical trials, achieving 100% concordance with the Center for Disease Control and Prevention’s (CDC's) mpox test on the samples tested, Cue Health said.
March 20, 2023
Cue Health Q4 revenues decline 24% as firm expands, diversifies POC test menu
The company’s revenues have come predominantly from its COVID-19 testing product, but it is "executing well" on its strategy of expanding the test menu, CEO Ayub Khattak said.
March 16, 2023
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
Specifically, the warning states that reports of adverse events after use of the vaccine under emergency use authorization (EUA) suggest increased risks of myocarditis and pericarditis, particularly from zero through seven days following vaccination.
March 14, 2023
Becton Dickinson nabs FDA clearance for infectious vaginitis molecular test
The BD vaginal panel running on the high-throughput BD Cor molecular diagnostic system tests for multiple common types of vaginitis using only a swab and one test.
March 16, 2023
Chembio CEO urges stockholders to tender remaining shares as deadline is extended for acquisition
Chembio “faces ongoing operational and financial challenges” if it remains an independent company, its CEO wrote in a letter to stockholders.
March 15, 2023
Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics
Immucor's transfusion and transplant product lines complement Werfen's hemostasis, acute care, and autoimmunity business lines, and expand the parent firm's portfolio of specialized diagnostic products for hospitals and clinical laboratories.
March 15, 2023
Most Popular
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
Chembio CEO urges stockholders to tender remaining shares as deadline is extended for acquisition
Cue Health Q4 revenues decline 24% as firm expands, diversifies POC test menu
Chicago man indicted for COVID-19 testing fraud
A Chicago lab that he co-owned obtained more then $83 million from the HRSA Uninsured Program as payment for COVID-19 tests purportedly performed by the laboratory, a U.S. Attorney's Office said.
March 14, 2023
Paige, Leica Biosystems expand partnership to enhance digital pathology workflows
Under the partnership, a co-branded version of Paige’s pathology platform will be introduced as the core interface between pathologists and Leica Biosystems hardware.
March 13, 2023
PerkinElmer completes divestiture of Applied, Food, and Enterprise Services businesses to New Mountain Capital
The company said that its Life Sciences and Diagnostics business resulting from the divestiture will focus on developing and delivering novel scientific breakthroughs.
March 13, 2023
Cue Health launches at-home diagnostic tests, expands test-to-treat service
March 13, 2023
Calibre Scientific acquires AlphaScience to expand product portfolio, customer reach
AlphaScience will be integrated with Biozol Diagnostica, a subsidiary of Calibre Scientific, expanding its sales capabilities and product range for customers in the DACH region that comprises Germany, Austria, and Switzerland.
March 13, 2023
DnaNudge, Mylab to develop MDx tests for diabetic foot infections, other health conditions
DnaNudge anticipates that its multiplex tests will enable health teams to identify the specific microbiological organisms responsible for each foot infection, providing antimicrobial resistance results in just over an hour.
March 13, 2023
Page 1 of 148
Next Page
